Experts in providing molecular products and services for oncology testing

Invivoscribe® is a global technology-driven cancer diagnostics company. Our mission is to optimize patient care and accelerate drug approvals worldwide by providing best-in-class products and services.

Invivoscribe provides a comprehensive selection of PCR-based products, including B- & T-cell clonality assays (IGH, IGK, TRG, TRB), chromosome translocations, the LeukoStrat® CDx FLT3 Mutation Assay, NGS gene panels and minimal residual disease (MRD) solutions with bioinformatics software.

Invivoscribe solutions are available as research use only testing reagents and controls as well as CE-marked in vitro diagnostic products.

Improving Lives with Precision Diagnostics®

Bio-Connect supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.

Major product lines from Invivoscribe

  • LymphoTrack® Dx (B- and T-cell clonality NGS Assays)
  • LeukoStrat® CDx FLT3 Mutation Assay
  • IdentiClone® (B- and T-cell clonality, FLT3 and translocation ABI Fluorescence Detection Assays)
  • MRD clonality solutions
  • FLT3 ITD MRD and NPM1 MRD Assays
  • Gene translocations
  • DNA and RNA controls, sensitivity- and proficiency-panels

Generating clinically actionable results that optimize treatments

Invivoscribe’s assays inform and guide the patient’s physician from diagnosis through the entire course of therapy.


Top sellers



Invivoscribe Corporate Video

More about Invivoscribe

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support